DSM Biomedical and its Berkeley based operation, DSM PTG, announced the company has entered into six multi-year licensing agreements with global medical device manufacturers in the Orthopedic, Cardiovascular, Vascular and Urology fields in this year alone. These medical device companies will be in a position to leverage the track record of DSM Biomedical’s advanced biomedical materials, including Bionate® PCU, CarboSil® TSPCU and ComfortCoat® medical coatings in applications such as total disk replacement and spinal stabilization.

Read the full story here

Patients subjected to major orthopedic surgery seem to face a risk of developing a blood clot within a vein, known as venous thromboembolism (VTE). However, experts from the McMaster University say that this risk can be reduced by the usage of an ultra-low-molecular-weight heparin called semuloparin.
Read the full story here.

Kyocera Industrial Ceramics Corporation has been appointed the official North American representative for Japan Medical Materials Corporation (JMM) for the sales of biocompatible ceramic structural components used in orthopedic systems. JMM components are immediately available from Kyocera to manufacturers of medical implant products, including “total hip” and “total knee” joint-replacement systems. The components include a wide range of biocompatible ceramics, including alumina and zirconia; bioactive coatings, such as hydroxyapatite; medical-grade alloys, such as titanium and vanadium-free titanium; and medical-grade ultra-high-molecular-weight polyethylene (UHMWPE).